Company profilePharmaceutical#19 of 1,318 in Pakistan1 DRAP alert

SHAIGAN PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 372 brands · 310 molecules

Ranked #5 of 58 companies in Skin Conditions

372 registered products 75 pharmaceutical brands 310 distinct molecules 1 DRAP alert

Company overview

372
registered products
75
pharmaceutical brands
310
distinct molecules
12
therapeutic classes
1
DRAP alerts

SHAIGAN PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 372 product registrations across 310 distinct molecules. It is the 19th largest registrant in Pakistan by product count, and ranks 5th of 58 in Skin Conditions. Its portfolio is concentrated in Skin Conditions and Blood Glucose Lowering Drugs, Excluding Insulin. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SHAIGAN

225 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

156
ceilings with an approval date
2
not revised in 2+ years
2024
oldest approval year
20242
2025151
20263
Longest without revision

Top molecules by brand count

Empagliflozin10 brands
Eye9 brands
Paracetamol8 brands
Clotrimazole8 brands
Levofloxacin8 brands
Amikacin7 brands
Ceftriaxone7 brands
Azithromycin6 brands
Metformin6 brands
Vaginal5 brands

Therapeutic classes

Skin Conditions · 11Blood Glucose Lowering Drugs, Excluding Insulin · 8Antiinflammatory And Antirheumatic Products · 7Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 7Eye Conditions · 6Other Beta-Lactam, Cephalosporins & Penems · 6Antifungal For Dermatological · 5Gastro · 5Quinolone Antibacterials · 4Antihistamines For Systemic Use · 4Anti-Acne Preparations · 4Pain Management · 4

Conditions treated

Infection/Allergy · 4Ulcer/Reflux/Flatulence/Acidity · 3Acne/Topical · 3Pain Killers · 3Allergy/Infections · 2Glaucoma/Mydriasis · 2Dry Eye/Allergy · 2Scabies · 2Digestion · 1Eczema/Psoriasis/Dermatitis · 1General Infections · 1Fungal Infection · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official286 products · Rs 3.93 – Rs 51,733.95
DVAGO35 products · Rs 44.35 – Rs 4,772.7
Servaid48 products · Rs 56.75 – Rs 748
Median across source: Rs 304

Regulatory record

1 alert in the DRAP feed we track.

Drug Safety Alert: Risk of Tendon Disorders with Third-Generation Aromatase inhibitors
2023-10-26

Competitive set

Companies whose registered portfolio overlaps most with this one.

NEUTRO PHARMA (PVT) LTD.108 shared molecules
BIO LABS (PVT) LTD.94 shared molecules
Genix Pharma Private Limited92 shared molecules
VALOR PHARMACEUTICALS90 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 170 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline
NEUTRO PHARMA (PVT) LTD. holds 80 molecules not in this portfolio
AcetylcysteineAcyclovirAnastrazoleAnastrozoleAntimonyAripiprazole
GETZ PHARMA PAKISTAN (PVT) LTD. holds 213 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAmitriptyline

Get the full profile for SHAIGAN

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.